Article
Pharmacogenomic importance of pravastatin.
Pharmacogenomics - 1 Sept 2008
Peters Bas, Maitland-van der Zee Anke-Hilse
Abstract excerpt
In developed countries, cardiovascular disease is one of the leading causes of death. Among other statins, pravastatin is abundantly prescribed to reduce risk of coronary artery disease by lowering cholesterol. Genetic factors are thought to be partly responsible for the interindividual variation in the response to pravastatin. This article reviews the most important studies conducted on the pharmacogenetics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
